High expression of NR6A1 was observed in prostate cancer cell lines (DU145, PC3, LNCaP, and 22RV1), whereas WPMY-1 showed lower expression of NR6A1 (Figure S3). This evidence concerns the gene NR6A1 and Familial prostate cancer.